The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma

Intra-Arterial Chemotherapy for Malignant Gliomas: A Critical Analysis

(2017) J-K. Burkhardt et al.   INTERVENTIONAL NEURORADIOLOGY

Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study

(2012) J.Y. Jeon et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Status Quo—Standard-of-Care Medical and Radiation Therapy for Glioblastoma

(2012) Kevin P. Becker et al.   CANCER JOURNAL

A restricted cell population propagates glioblastoma growth after chemotherapy

(2012) Jian Chen et al.   NATURE

Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

(2011) Jan-Karl Burkhardt et al.   World Neurosurgery

Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea]

(2010) Eberval Gadelha Figueiredo et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors

(2010) Thomas Reithmeier et al.   BMC CANCER

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas

(2010) Jeffrey J. Raizer et al.   CANCER

Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma

(2010) Ufuk Abacioglu et al.   JOURNAL OF NEURO-ONCOLOGY

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

(2010) John A. Boockvar et al.   JOURNAL OF NEUROSURGERY

Standard Therapy for Glioblastoma— A Review of Where We Are

(2010) Ryo NISHIKAWA   NEUROLOGIA MEDICO-CHIRURGICA

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme

(2009) Tomokazu Aoki et al.   JOURNAL OF NEUROSURGERY

FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme

(2009) M. H. Cohen et al.   ONCOLOGIST

Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma

(2009) M. Glas et al.   ONCOLOGY

ACNU-based chemotherapy for recurrent glioma in the temozolomide era

(2008) Caroline Happold et al.   JOURNAL OF NEURO-ONCOLOGY

Cisplatin: a review of toxicities and therapeutic applications

(2008) K. Barabas et al.   Veterinary and Comparative Oncology